173 related articles for article (PubMed ID: 11868762)
21. Effect of amoxycillin/clavulanic acid on the aerobic and anaerobic tonsillar microflora in the treatment of recurrent tonsillitis.
Agren K; Lundberg C; Nord CE
Scand J Infect Dis; 1990; 22(6):691-7. PubMed ID: 2284575
[TBL] [Abstract][Full Text] [Related]
22. Effect of piperacillin/tazobactam treatment on human bowel microflora.
Nord CE; Brismar B; Kasholm-Tengve B; Tunevall G
J Antimicrob Chemother; 1993 Jan; 31 Suppl A():61-5. PubMed ID: 8383656
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic susceptibility of the bacteria causing odontogenic infections.
Brescó-Salinas M; Costa-Riu N; Berini-Aytés L; Gay-Escoda C
Med Oral Patol Oral Cir Bucal; 2006 Jan; 11(1):E70-5. PubMed ID: 16388299
[TBL] [Abstract][Full Text] [Related]
24. Comparative in vitro activities of torezolid (DA-7157) against clinical isolates of aerobic and anaerobic bacteria in South Korea.
Yum JH; Choi SH; Yong D; Chong Y; Im WB; Rhee DK; Lee K
Antimicrob Agents Chemother; 2010 Dec; 54(12):5381-6. PubMed ID: 20837761
[TBL] [Abstract][Full Text] [Related]
25. [Effect of BRL 25000 (clavulanic acid-amoxicillin) on bacterial flora in human feces].
Motohiro T; Tanaka K; Koga T; Shimada Y; Tomita N; Sakata Y; Fujimoto T; Nishiyama T; Kuda N; Ishimoto K
Jpn J Antibiot; 1985 Feb; 38(2):441-80. PubMed ID: 3847525
[TBL] [Abstract][Full Text] [Related]
26. Ecological effect of ceftazidime/avibactam on the normal human intestinal microbiota.
Rashid MU; Rosenborg S; Panagiotidis G; Löfdal KS; Weintraub A; Nord CE
Int J Antimicrob Agents; 2015 Jul; 46(1):60-5. PubMed ID: 25979639
[TBL] [Abstract][Full Text] [Related]
27. Impact of cefaclor on the normal human oropharyngeal and intestinal microflora.
Nord CE; Heimdahl A; Lundberg C; Marklund G
Scand J Infect Dis; 1987; 19(6):681-5. PubMed ID: 3441750
[TBL] [Abstract][Full Text] [Related]
28. Effect of beta-lactam prodrugs on human intestinal microflora.
Sjövall J; Huitfeldt B; Magni L; Nord CE
Scand J Infect Dis Suppl; 1986; 49():73-84. PubMed ID: 3547627
[TBL] [Abstract][Full Text] [Related]
29. Effect of piperacillin/tazobactam therapy on intestinal microflora.
Nord CE; Brismar B; Kasholm-Tengve B; Tunevall G
Scand J Infect Dis; 1992; 24(2):209-13. PubMed ID: 1322559
[TBL] [Abstract][Full Text] [Related]
30. [Effects of azithromycin on fecal flora of healthy adult volunteers].
Uchino U; Kanayama A; Hasegawa M; Kobayashi I; Muto H; Enogaki K; Matsunaga T; Ogawa M; Cyong JC; Kodama K
Jpn J Antibiot; 1995 Sep; 48(9):1119-30. PubMed ID: 7474332
[TBL] [Abstract][Full Text] [Related]
31. Impact of gemifloxacin on the normal human intestinal microflora.
Barker PJ; Sheehan R; Teillol-Foo M; Palmgren AC; Nord CE
J Chemother; 2001 Feb; 13(1):47-51. PubMed ID: 11233800
[TBL] [Abstract][Full Text] [Related]
32. [The antimicrobial activity of Augmentin (amoxicillin/clavulanic acid) compared to other antibacterial agents].
Zubkov MN; Nonikov VE; Gugutsidze EN; Sutormina TM; Makarova OV
Antibiot Khimioter; 1992 Sep; 37(9):34-6. PubMed ID: 1444669
[TBL] [Abstract][Full Text] [Related]
33. Impact of dirithromycin on the normal oral and intestinal microflora.
Eckernäs SA; Grahnén A; Nord CE
Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):688-92. PubMed ID: 1748127
[TBL] [Abstract][Full Text] [Related]
34. Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine.
Sullivan A; Barkholt L; Nord CE
J Antimicrob Chemother; 2003 Aug; 52(2):308-11. PubMed ID: 12865387
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates.
Cercenado E; García-Garrote F; Bouza E
J Antimicrob Chemother; 2001 Jan; 47(1):77-81. PubMed ID: 11152434
[TBL] [Abstract][Full Text] [Related]
36. Impact of cefixime on the normal intestinal microflora.
Nord CE; Movin G; Stålberg D
Scand J Infect Dis; 1988; 20(5):547-52. PubMed ID: 3222669
[TBL] [Abstract][Full Text] [Related]
37. Activity of linezolid against 3,251 strains of uncommonly isolated gram-positive organisms: report from the SENTRY Antimicrobial Surveillance Program.
Jones RN; Stilwell MG; Hogan PA; Sheehan DJ
Antimicrob Agents Chemother; 2007 Apr; 51(4):1491-3. PubMed ID: 17210770
[TBL] [Abstract][Full Text] [Related]
38. Ecological impact of MCB3837 on the normal human microbiota.
Rashid MU; Dalhoff A; Bäckström T; Björkhem-Bergman L; Panagiotidis G; Weintraub A; Nord CE
Int J Antimicrob Agents; 2014 Aug; 44(2):125-30. PubMed ID: 24931053
[TBL] [Abstract][Full Text] [Related]
39. Effect of lomefloxacin on the normal oral and intestinal microflora.
Edlund C; Brismar B; Nord CE
Eur J Clin Microbiol Infect Dis; 1990 Jan; 9(1):35-9. PubMed ID: 2303064
[TBL] [Abstract][Full Text] [Related]
40. Treatment options for vancomycin-resistant enterococcal infections.
Linden PK
Drugs; 2002; 62(3):425-41. PubMed ID: 11827558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
